Search
Now showing items 1-5 of 5
South Africa and the COVID-19 vaccine
(José Frantz, 2021)
Scientists, public health experts and politicians have been telling
us that, to stop Covid-19, we need to embark on a massive vaccine
rollout. But do we really need to vaccinate more than 70% of our
population to stop ...
Knowledge and awareness of human papillomavirus and intention with regard to human papillomavirus vaccine uptake by female tertiary students in the Eastern Cape province
(MedPharm, 2013)
In 2008, two human papillomavirus (HPV) vaccines, Cervarix and Gardasil, were licensed for use in South Africa. Initial models
showed that vaccination could lead to an approximate 70% decline in cervical cancer cases. ...
The past is so present: Understanding Covid‑19 vaccine hesitancy among African American adults using qualitative data
(Springer, 2022)
African Americans (AAs) are disproportionately afected by structural and social determinants of health, resulting in greater risks of exposure to and deaths from COVID-19. Structural and social determinants of health feed ...
Covid-19 vaccine effectiveness studies in Nigeria: Quo vadis?
(International Society of Global Health, 2022)
The “lickety-split” development of COVID-19 vaccines 326 days from when the SARS-COV-2 virus was
first sequenced is indeed one of the public health successes of the 21st century. Particularly because an
18-month target ...
A plant-produced SARS-CoV-2 spike protein elicits heterologous immunity in hamsters
(Frontiers Media, 2023)
Molecular farming of vaccines has been heralded as a cheap, safe and scalable
production platform. In reality, however, differences in the plant biosynthetic
machinery, compared to mammalian cells, can complicate the ...